Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11400069 Methods of treating mixed dyslipidemia
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
December 1, 2021
0
Date of Patent
August 2, 2022
0
Patent Application Number
17457160
0
Patent Citations
US Patent 11033523 Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
US Patent 11213504 Stable pharmaceutical composition and methods of using same
US Patent 11179362 Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
0
US Patent 10058521 Omega-3 pentaenoic acid compositions and methods of use
US Patent 10166209 Methods of reducing apolipoprotein C-III
US Patent 10220013 Methods of treating mixed dyslipidemia
US Patent 10265290 Methods of reducing apolipoprotein C-III
US Patent 10278935 Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
0
US Patent 10555925 Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
0
US Patent 10441593 Treatment of pain associated with dislocation of endometrium
0
•••
Patent Inventor Names
Ian Osterloh
0
Mehar Manku
0
Paresh Soni
0
Pierre Wicker
0
Rene Braeckman
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11400069
0
Patent Primary Examiner
Kevin E. Weddington
0
CPC Code
A61K 31/202
0
A61K 31/232
0
A61K 31/40
0
Find more entities like US Patent 11400069 Methods of treating mixed dyslipidemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE